Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - methylprednisolone sodium succinate -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - erythromycin lactobionate - powder for solution for infusion - 1gram

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - cytarabine, quantity: 1000 mg - injection, solution - excipient ingredients: water for injections; macrogol 400; trometamol - cytarabine is indicated primarily for:,? induction and maintenance of remission in acute myelocytic leukaemia of both adults and children.,it has also been found to be useful in the treatment of other leukaemias such as:,? acute lymphocytic leukaemia,? chronic myelocytic leukaemia (blast phase).,cytarabine may be used alone or in combination with other antineoplastic agents, the best results are often obtained with combination therapy.,children with non-hodgkin?s lymphoma have benefited from a combination drug program (lsa2l2) that includes cytarabine.,remissions induced by cytarabine not followed by maintenance treatment have been brief. maintenance therapy has extended these and provided useful and comfortable remissions with relatively little toxicity.,cytarabine has been used intrathecally in meningeal leukaemia. focal leukaemic involvement of the central nervous system may not respond to intrathecal cytarabine and may better be treated with radiotherapy.

Singapore - English - HSA (Health Sciences Authority)

pharmakoe pte. ltd. - cefotaxime sodium equivalent to cefotaxime - injection, powder, for solution - cefotaxime sodium equivalent to cefotaxime 0.5g/vial

Singapore - English - HSA (Health Sciences Authority)

pharmakoe pte. ltd. - cefotaxime sodium equivalent to cefotaxime - injection, powder, for solution - cefotaxime sodium equivalent to cefotaxime 1g/vial

New Zealand - English - Medsafe (Medicines Safety Authority)

asta medica australasia pty (nz) limited - methylprednisolone sodium succinate 1000mg - solution for injection - 1000 mg - active: methylprednisolone sodium succinate 1000mg excipient: dibasic sodium phosphate dodecahydrate monobasic sodium phosphate dihydrate water for injection

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - methylprednisolone (unii: x4w7zr7023) (methylprednisolone - unii:x4w7zr7023) - methylprednisolone tablets are indicated in the following conditions: primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoids supplementation is of particular importance). congenital adrenal hyperplasia nonsuppurative thyroiditis hypercalcemia associated with cancer as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy) ankylosing spondylitis acute and subacute bursitis synovitis of osteoarthritis acute nonspecific tenosynovitis post-traumatic osteoarthritis psoriatic arthritis epicondylitis acute gouty arthritis during an exacerbation or as maintenance therapy in selected cases of: systemic lupus erythematosus systemic dermatomyositis (polymyositis) acute rheumatic cardit

United States - English - NLM (National Library of Medicine)

avera mckennan hospital - methylprednisolone (unii: x4w7zr7023) (methylprednisolone - unii:x4w7zr7023) - methylprednisolone 4 mg

United States - English - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - methylprednisolone (unii: x4w7zr7023) (methylprednisolone - unii:x4w7zr7023) - methylprednisolone 4 mg

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - methylprednisolone (unii: x4w7zr7023) (methylprednisolone - unii:x4w7zr7023) - methylprednisolone 4 mg